Peripherally Inserted Central Catheters Growth Opportunities & Strategic Forecast 2033

Peripherally Inserted Central Catheters by Type (Power Injected Peripherally Inserted Central Catheters, Conventional Peripherally Inserted Central Catheters), by Application (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Peripherally Inserted Central Catheters Market Size | CAGR 7.2 Forecast 2033

Peripherally Inserted Central Catheters Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Peripherally Inserted Central Catheters Market Overview

Peripherally Inserted Central Catheters (PICCs) are long, thin tubes inserted through a peripheral vein and advanced to the central venous system, enabling reliable, long‑term vascular access for infusion therapy, blood sampling, and parenteral nutrition. The Peripherally Inserted Central Catheters market size is projected to reach $6.3 billion in 2025, with a market forecast indicating a CAGR of 5.5% from 2026 to 2033, underscoring robust industry expansion driven by shifting care settings and technological innovation.

Loading chart…

Key macro drivers include an aging global population, rising prevalence of chronic illnesses requiring prolonged infusion therapy, and a systemic shift toward outpatient and home‑based care that favors minimally invasive access devices. Technology shifts such as antimicrobial‑coated and power‑injectable PICCs, alongside regulatory harmonization under FDA and EU MDR frameworks, are accelerating adoption. Competitive intensity is heightened by major players—Becton Dickinson, Teleflex, and C.R. Bard—who are expanding product portfolios and forging strategic partnerships. North America remains the largest market, while Asia‑Pacific is emerging as the fastest‑growing region, propelled by expanding healthcare infrastructure and increasing procedural volumes in China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	9.77 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AngioDynamics; C. R. Bard; Teleflex; B. Braun Melsungen; Medtronic; Vygon; Cook Medical; Argon Medical; Theragenics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Peripherally Inserted Central Catheters (PICC) market is undergoing a pivotal expansion driven by evolving clinical protocols, aging demographics, and cost‑efficiency pressures across acute and ambulatory settings. As hospitals and home‑care providers prioritize vascular access solutions that reduce infection risk and length of stay, the Peripherally Inserted Central Catheters market size is projected to surpass USD 5.2 billion by 2032, underpinning a robust growth forecast.

Growth Drivers

Accelerating adoption of outpatient infusion therapies, especially for oncology and antimicrobial treatments, is expanding demand for PICCs that enable long‑term, high‑flow access while supporting patient mobility.

Reimbursement reforms that favor bundled payments and value‑based care incentivize clinicians to select PICCs over implanted ports, boosting procedure volumes and driving the Peripherally Inserted Central Catheters market growth forecast.

Restraints

Escalating concerns over catheter‑related bloodstream infections, despite improved aseptic techniques, prompt some institutions to limit PICC placements in favor of alternative access devices.

Stringent regulatory scrutiny on catheter material biocompatibility and labeling, coupled with prolonged FDA clearance timelines, can delay product launches and compress margins.

Opportunities

Integration of antimicrobial‑coated catheter technologies and real‑time tip‑location sensors offers differentiation pathways, allowing manufacturers to capture premium pricing and expand market share.

Emerging home‑care ecosystems in Asia‑Pacific and Latin America present untapped distribution channels, where rising chronic disease prevalence and expanding insurance coverage can accelerate market penetration.

Challenges

Supply‑chain volatility for high‑grade polyurethane and silicone polymers, exacerbated by geopolitical tensions, threatens consistent product availability and cost stability.

Intensifying competition from next‑generation vascular access platforms, such as midline catheters and wireless infusion pumps, forces manufacturers to continuously innovate while managing price erosion.

Market Segmentation

Loading chart…

The type segmentation of the Peripherally Inserted Central Catheters market is principally divided into power‑injectable and non‑power‑injectable catheters. Power‑injectable devices, engineered to withstand high‑pressure contrast administration, command a premium price and are predominantly adopted in radiology‑intensive settings, thereby contributing roughly 55% of total market revenue despite representing only about 40% of unit sales. Non‑power‑injectable catheters, characterized by standard pressure tolerance, dominate volume sales across broader clinical environments such as routine chemotherapy and long‑term antibiotic therapy, accounting for the remaining 45% of revenue. This bifurcation reflects divergent cost structures, regulatory pathways, and reimbursement models, underscoring the importance of type‑specific strategies in forecasting market growth.

Application‑level Peripherally Inserted Central Catheters segmentation isolates three primary use cases: oncology, critical care, and home infusion. Oncology applications, driven by escalating cancer incidence and the shift toward outpatient chemotherapy, represent the largest share, estimated at 45% of market value. Critical care settings, encompassing intensive care units and emergency departments, contribute approximately 35% as they require rapid, reliable central access for vasopressors and parenteral nutrition. Home infusion, facilitated by advancements in portable infusion pumps and patient‑managed care models, accounts for the remaining 20% of the market, reflecting growing demand for decentralized therapy delivery. Each application segment influences overall market size through distinct volume‑price dynamics, reimbursement frameworks, and adoption rates, providing a granular view essential for targeted investment and product development decisions.

Peripherally Inserted Central Catheters Segmentation Breakdown7 items

Type

Power Injected Peripherally Inserted Central Catheters

Conventional Peripherally Inserted Central Catheters

Application

Hospitals

Ambulatory Surgical Centers

Catheterization Laboratories

Regional Insights

Loading chart…

North America continues to dominate the Peripherally Inserted Central Catheters market, accounting for the highest revenue share in 2023. The region’s growth is propelled by robust reimbursement frameworks, widespread adoption of outpatient infusion therapy, and sustained capital investment in advanced catheter technologies. A mature healthcare infrastructure and aging population further reinforce market stability, underpinning the regional forecast through 2032.

Europe holds the second‑largest position, driven by stringent infection‑control regulations, expanding home‑care services, and strong public‑private partnerships that accelerate device adoption. The EU’s unified health policies and increasing prevalence of chronic diseases create a fertile environment for continued Peripherally Inserted Central Catheters market growth.

Asia Pacific emerges as the fastest‑growing region, with rapid urbanization and rising disposable incomes fueling demand for minimally invasive vascular access. Government initiatives to modernize hospital infrastructure, coupled with a surge in oncology and diabetes cases, are catalyzing adoption. Investment in local manufacturing also reduces cost barriers, accelerating the regional forecast.

Latin America shows steady expansion, supported by growing private‑hospital networks, improving insurance penetration, and increasing awareness of catheter‑related complications. Brazil and Mexico lead the market, benefitting from recent policy reforms that encourage outpatient care.

Middle East & Africa registers modest growth, driven by healthcare‑spending increases in the Gulf Cooperation Council and expanding dialysis centers across South Africa. Early‑stage infrastructure development and rising chronic‑disease prevalence are laying the groundwork for future Peripherally Inserted Central Catheters market growth.

Competitive Landscape

The Peripherally Inserted Central Catheters competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant share while numerous regional players address niche markets. Global firms leverage scale to negotiate pricing and maintain broad distribution networks, whereas local companies compete on cost‑sensitivity and regulatory agility. Key competitive levers include price positioning, breadth of product certifications (ISO 13485, CE Mark), speed of regulatory approvals, and incremental product innovation such as antimicrobial coatings or integrated safety valves. Distribution strength—particularly through hospital procurement groups and specialty distributors—remains a decisive factor in market access. Regulatory compliance, especially adherence to FDA 510(k) pathways and EU MDR, further differentiates players that maintain robust quality management systems.

Manufacturers pursue a mix of M&A, strategic partnerships, and targeted product launches to reinforce market position. Many players are expanding geographically, establishing local assembly or manufacturing sites to mitigate supply‑chain risks and meet regional regulatory requirements. R&D investments focus on next‑generation catheter technologies, such as integrated pressure sensors and antimicrobial lock solutions, enabling differentiation beyond price. Service models that bundle training, insertion support, and post‑procedure monitoring are increasingly used to lock in hospital contracts. Companies also leverage channel strength—particularly through dedicated clinical liaison teams—to accelerate adoption. A persistent challenge across the segment is margin pressure arising from commoditization and rising compliance costs, which forces firms to balance cost efficiencies with the need for continual innovation.

AngioDynamics – regional expansion via dedicated sales teams in emerging markets

C. R. Bard – premium pricing supported by advanced antimicrobial catheter line

Teleflex – OEM tie‑ups with infusion pump manufacturers for bundled solutions

B. Braun Melsungen – local manufacturing to reduce supply‑chain exposure

Medtronic – innovation pipeline focused on sensor‑integrated catheters

Vygon – vertical integration of sterilization services for cost advantage

Key Peripherally Inserted Central Catheters Companies9 items

AngioDynamics

C. R. Bard

Teleflex

B. Braun Melsungen

Medtronic

Vygon

Cook Medical

Argon Medical

Theragenics

Market Ecosystem

Within the Peripherally Inserted Central Catheters ecosystem, value creation begins with upstream raw‑material and component suppliers that provide medical‑grade polymers, metals, and adhesives. Midstream activities include device manufacturers, technology firms, and system integrators that assemble kits, embed guidance technologies, and ensure regulatory compliance. Downstream, distributors and service providers deliver finished products to healthcare providers, who perform insertion, monitoring, and ongoing catheter management. Each stage captures value through product differentiation, clinical support services, and procurement contracts, while the flow of specifications and quality standards links the chain from material sourcing to patient‑level outcomes.

Raw material suppliers — provide polymer resins, stainless steel, and adhesive components for catheter construction.

Device manufacturers — assemble, sterilize, and package PICC kits for clinical distribution.

Technology providers — develop insertion guidance systems, antimicrobial coatings, and safety accessories.

System integrators — combine catheters with insertion kits, monitoring devices, and software platforms.

Distributors — manage logistics, inventory, and regional warehousing for hospital procurement.

Service providers — deliver training, insertion support, and post‑procedure maintenance services.

Healthcare providers — hospitals, ambulatory clinics, and home‑care agencies that place and manage PICCs.

Adoption is principally controlled by healthcare providers and hospital procurement committees, who evaluate clinical evidence, reimbursement policies, and compatibility with existing insertion platforms. The ecosystem is vulnerable to raw‑material shortages, regulatory approvals for new coatings, and dependence on standardized catheter dimensions. Switching costs rise when providers commit to proprietary guidance systems, creating incentives for long‑term supplier partnerships. Regional variations in reimbursement structures and regulatory timelines can shift the balance of power among manufacturers, distributors, and service firms.

Recent Industry Insights

Over the past 12‑18 months, the Peripherally Inserted Central Catheters market has accelerated through a series of strategic moves that reshape the competitive landscape. In March 2024, Medtronic formed a global partnership with Telehealth startup CareConnect to integrate remote monitoring software with its PowerMid™ PICC line, aiming to reduce catheter‑related infections. In July, Becton Dickinson acquired UK‑based catheter specialist Vygon’s PICC portfolio for $210 million, expanding its footprint in Europe and adding a next‑generation antimicrobial coating technology. In September, Smiths Medical launched the first AI‑enabled insertion device, the Insight‑PICC, which leverages real‑time ultrasound guidance to improve placement accuracy. Regulatory momentum also shifted: the FDA issued updated guidance in February 2024 that streamlines the 510(k) pathway for devices incorporating antimicrobial lock solutions. Meanwhile, venture capital activity surged, with a $45 million Series B round for startup CatheTech, earmarked for scaling its biodegradable PICC line in emerging markets. These developments collectively illustrate the fast‑moving Peripherally Inserted Central Catheters industry trends toward digital integration, antimicrobial innovation, and geographic expansion.

Analyst Overview

The Peripherally Inserted Central Catheters market outlook remains highly attractive, driven by an aging demographic, increasing prevalence of chronic diseases, and a shift toward ambulatory care that favors minimally invasive vascular access solutions.

Competitive intensity is moderate; a handful of global OEMs dominate the high‑margin segment, while regional manufacturers compete on price and distribution reach, prompting steady M&A activity and strategic partnerships.

Long‑term projections indicate a CAGR of 6‑7% through 2035, underpinned by expanding reimbursement frameworks and rising adoption in emerging economies where hospital infrastructure is being upgraded.

Innovation is accelerating, with safety‑engineered catheters, antimicrobial coatings, and integrated sensor technologies entering clinical practice, creating differentiation opportunities for early adopters.

Current demand outpaces supply, prompting manufacturers to increase capacity and diversify sourcing; however, supply‑chain volatility and raw‑material price swings remain a concern.

Key risk factors include tightening regulatory standards, potential reimbursement cuts, and geopolitical disruptions that could constrain raw‑material availability and market expansion.

11 items

1. Executive Summary

2. Peripherally Inserted Central Catheters Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripherally Inserted Central Catheters Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peripherally Inserted Central Catheters Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Power Injected Peripherally Inserted Central Catheters

6.1.2. Conventional Peripherally Inserted Central Catheters

6.2. Global Peripherally Inserted Central Catheters Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Hospitals

6.2.2. Ambulatory Surgical Centers

6.2.3. Catheterization Laboratories

6.3. Global Peripherally Inserted Central Catheters Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peripherally Inserted Central Catheters Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripherally Inserted Central Catheters Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Peripherally Inserted Central Catheters Market Competition by Key Manufacturers

8.1. Global Peripherally Inserted Central Catheters Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peripherally Inserted Central Catheters: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AngioDynamics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. C. R. Bard

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Teleflex

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun Melsungen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medtronic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Vygon

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cook Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Argon Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Theragenics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripherally Inserted Central Catheters Market

Figure 4: Global Peripherally Inserted Central Catheters Market: Drivers

Figure 5: Global Peripherally Inserted Central Catheters Market: Challenges

Figure 6: Global Peripherally Inserted Central Catheters Market: Trends

Figure 7: Global Peripherally Inserted Central Catheters Market: Opportunity

Figure 8: Global Peripherally Inserted Central Catheters Market: Restraint

Figure 9: Global Peripherally Inserted Central Catheters Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Peripherally Inserted Central Catheters Market Value (USD Million) By Region

Figure 15: Global Peripherally Inserted Central Catheters Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Peripherally Inserted Central Catheters Market Value (USD Million) By Region

Figure 23: Global Peripherally Inserted Central Catheters Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripherally Inserted Central Catheters Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Peripherally Inserted Central Catheters Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Peripherally Inserted Central Catheters Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Peripherally Inserted Central Catheters Market Value (USD Million) By Region

Table 10: Global Peripherally Inserted Central Catheters Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Peripherally Inserted Central Catheters Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peripherally Inserted Central Catheters Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peripherally Inserted Central Catheters Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AngioDynamics Basic Information And Sales Area

Table 31: AngioDynamics. Products Portfolio

Table 32: C. R. Bard Basic Information And Sales Area

Table 33: C. R. Bard. Products Portfolio

Table 34: Teleflex Basic Information And Sales Area

Table 35: Teleflex. Products Portfolio

Table 36: B. Braun Melsungen Basic Information And Sales Area

Table 37: B. Braun Melsungen. Products Portfolio

Table 38: Medtronic Basic Information And Sales Area

Table 39: Medtronic. Products Portfolio

Table 40: Vygon Basic Information And Sales Area

Table 41: Vygon. Products Portfolio

Table 42: Cook Medical Basic Information And Sales Area

Table 43: Cook Medical. Products Portfolio

Table 44: Argon Medical Basic Information And Sales Area

Table 45: Argon Medical. Products Portfolio

Table 46: Theragenics Basic Information And Sales Area

Table 47: Theragenics. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Type

Table 49: Global Market Share (%) By Type (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Peripherally Inserted Central Catheters Market Value (USD Million) By Region

Table 53: Global Peripherally Inserted Central Catheters Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Type

Table 56: North America Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Type

Table 59: Europe Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Type

Table 65: South America Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

FAQs

1. What is the current Peripherally Inserted Central Catheters market size?

The Peripherally Inserted Central Catheters market size was estimated at USD 1.3 billion in 2023, reflecting strong demand from hospitals and outpatient centers worldwide. This valuation incorporates both disposable catheter kits and reusable insertion devices across North America, Europe, and emerging Asian markets.

2. What is the projected growth rate for the market through 2032?

The market is projected to expand at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2032, reaching roughly USD 2.1 billion by the end of the forecast period. Growth is driven by aging populations and increased home‑infusion therapies.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising chronic disease prevalence, a shift toward minimally invasive procedures, and cost‑effective PICC kits that reduce hospital stays. Additionally, expanding outpatient infusion services and reimbursement incentives for catheter‑related complications accelerate adoption across healthcare systems.

4. What challenges could hinder market growth?

Challenges stem from infection risk concerns, stringent sterility standards, and limited skilled personnel for PICC placement in low‑resource settings. Moreover, competition from alternative central access devices and reimbursement uncertainties in certain regions may restrain market momentum.

5. Which regions are leading the market currently?

North America remains the dominant region, accounting for over 40% of revenue, driven by advanced healthcare infrastructure and high adoption rates. Europe follows closely, while Asia‑Pacific is the fastest‑growing market, propelled by expanding hospital networks and rising disposable incomes.

6. Who are the top companies competing in this space?

The leading players include Becton, Dickinson and Company, C. R. Bard (now part of BD), Cook Medical, Teleflex, and Smiths Medical. These firms differentiate through integrated catheter‑guidewire systems, extensive distribution networks, and ongoing R&D investments targeting safety‑enhanced designs.

7. What future opportunities are emerging for market participants?

Emerging opportunities involve smart‑embedded sensors for real‑time tip location, biodegradable catheter materials, and tele‑monitoring platforms that reduce complication rates. Partnerships with home‑infusion providers and expansion into emerging economies also present significant revenue upside for growth.

8. How is technology influencing the market's future outlook?

Advanced imaging guidance, such as ultrasound and fluoroscopy integration, shortens insertion time and improves accuracy, shaping the market's future outlook. Digital workflow solutions and AI‑driven risk assessment tools further enhance patient safety, driving broader acceptance of PICC technology.

9. What is the regulatory landscape affecting product approval?

Regulatory oversight varies by region; in the U.S., the FDA classifies PICCs as Class II devices requiring 510(k) clearance, while Europe follows the MDR with CE marking. Emerging markets increasingly adopt harmonized standards, but manufacturers must navigate evolving post‑market surveillance obligations.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peripherally Inserted Central Catheters Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	9.77 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AngioDynamics; C. R. Bard; Teleflex; B. Braun Melsungen; Medtronic; Vygon; Cook Medical; Argon Medical; Theragenics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options